𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunohistochemical detection of p53 in non-malignant and malignant oral lesions associated with snuff dipping in the Sudan and Sweden

✍ Scribed by Salah O. Ibrahim; Anne C. Johannessen; Ali M. Idris; Jan M. Hirsch; Endre N. Vasstrand; Bengt Magnusson; Rune Nilsen


Book ID
102654687
Publisher
John Wiley and Sons
Year
1996
Tongue
French
Weight
724 KB
Volume
68
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Immunohistochemistry was used to examine the expression of p53 in pre-malignant oral lesions and oral squamous-cell carcinomas (SCCs) from Swedish and Sudanese snuff-dippers, as well as in pre-malignant oral lesions and oral SCCs from non-snuff-dippers from the Sudan, Sweden and Norway. Of the I4 SCCs from Sudanese snuff-dippers, 2 I % (3/ 14) expressed p53. Of the 14,60 and 4 I SCCs from non-snuff-dippers from the Sudan, Sweden and Norway, 64% (9/ 14). 65% (39/60) and 68% (28/4 I) expressed p53, respectively. A statistically significant difference in expression of p53 was found in SCCs from Sudanese snuff-dippers compared to those from non-snuff-dippers from all/or any of the 3 countries. None of the suspected pre-malignant oral lesions from Sudanese snuff dippers or non-snuff-dippers expressed p53. Only 2 out of the I5 oral fibro-epithelial hyperplastic lesions from Swedish snuff-dippers expressed p53. Some of the oral epithelial dysplastic lesions, as well as the carcinoma in situ lesions from Norwegian non-snuffdippers, expressed p53, while the oral fibro-epithelial hyperplastic lesions did not. The low relative frequency of p53 expression found in oral SCCs from snuff-dippers compared to those from non-snuff-dippers might suggest differences in mechanisms of oncogenic action induced by snuff. Alternatively, the pathogenesis of malignant oral lesions from snuff-dippers may follow a p53-independent pathway. In view of the unusually high levels of the tobacco-specific nitrosamines (TSNA) found in the type of snuff used in the Sudan, investigations of p53 mutations or oncogenes are needed.


πŸ“œ SIMILAR VOLUMES


P-glycoprotein is positively correlated
✍ Ranju Ralhan; Rajeeb K. Swain; Sandhya Agarwal; Jasbir Kaur; Neera Nath; Gautam πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 282 KB πŸ‘ 2 views

P-glycoprotein (Pgp) encoded by the MDR1 gene, a predictor of chemoresistance, may also serve as a prognosticator of clinical outcome in cancer patients. The mutant tumour-suppressor p53 protein has been shown to activate the MDR1 promoter, whereas the wild-type p53 represses this activity in cultur

A low incidence of p53 mutations in pre-
✍ P. Lazarus; H. S. Garewal; J. Sciuuba; N. Zwiebel; A. Calcagnotto; A. Fair; S. S πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 1000 KB

## Abstract To determine the incidence of __pS3__ mutations in pre‐malignant lesions of the oral cavity from individuals without prior history of tobacco use, we have analyzed the conserved regions of the __pS3__ gene (exons 5‐9) in archival oral cavity lesion specimens obtained from patients with

Mutations of the p53 gene in oral squamo
✍ Salah O. Ibrahim; Endre N. Vasstrand; Anne C. Johannessen; Ali M. Idris; Bengt M πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 100 KB πŸ‘ 2 views

Using PCR-SSCP/DNA sequencing methods, we analyzed 14 oral squamous-cell carcinomas (OSCCs) and 8 premalignant oral lesions from different Sudanese patients for prevalence of mutations in exons 5 to 9 of the p53 gene in relation to toombak-dipping status. OSCCs (14 from Sudan, 28 from Scandinavia),